17 March 2026
Aptar appoints Gael Touya CEO effective Sept 1, 2026; Stephan Tanda to retire end-2026
Gael Touya, a 30-year veteran, led the Pharma unit’s transformation (~82% sales growth) and has global commercial and operational experience. Tanda raised margins, EPS and sustainability.